Nearly 50 new cancer therapies are approved every year. This is good news. "But for patients and their treating physicians, ...

Researchers at McGill University are working on a new organ chip that will allow them to predict how cancer treatment will ...

Esther Ugwueke is a biomedical expert and PhD student at the University of Nebraska Medical Center, United States, where she studies and researches lung cancer using bioinformatics, artificial ...

Prostate cancer is highly heterogeneous, ranging from slow-growing tumors to aggressive, life-threatening disease.

The key market opportunities in next-generation oncology devices include enhancing precision diagnostics and targeted ...

Triple-negative breast cancer (TNBC), the deadliest breast cancer subtype, disproportionately affects African American women – but until now, they were underrepresented in genomic studies aimed at ...

The result was the first complete inventory of human gut microbiota subspecies, along with a method for using it in both ...

Despite significant advancements in medicine, cancer remains a major health challenge and the leading cause of mortality worldwide, highlighting the urgent need for continued research to identify ...

Market opportunities in pet oncology include leveraging breakthroughs in immunotherapy and precision medicine. Tailored treatment plans, enhanced by bioinformatics and genomic profiling, foster ...

Researchers have discovered that statins, drugs typically used for high cholesterol, could potentially slow the growth of colorectal cancer cells.